Potential clinical use of butyric acid derivatives to induce antigen-specific T cell inactivation

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 1146-1153

  Gilbert, K M ^a   Wahid, R ^a   Portabella Fecher, N ^a   Freeman, J P ^a   Kim Fifer, E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 MORPHOLINYL)ETHYL BUTYRATE HYDROCHLORIDE; BUTYRIC ACID DERIVATIVE; DNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; DNA DETERMINATION; DRUG EFFECT; IMMUNOTHERAPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS; BUTYRATES; BUTYRIC ACIDS; CELL DIVISION; CELLS, CULTURED; G1 PHASE; INTERLEUKIN-2; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MORPHOLINES; OVALBUMIN; PIPERAZINES; TH1 CELLS;

EID: 0033846734     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Complexities of applying nasal tolerance induction as a therapy for ongoing relapsing experimental autoimmune encephalomyelitis (EAE) in DA rats
2. Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts
3. Visualization of specific B and T lymphocyte interactions in the lymph node
4. Modulation of experimental anteimmune neuritis in Lewis rats by oral application of myelin antigens
5. Th1 and Th2 clones differ in their response to a tolerogenic signal
6. Th1 cell anergy and blockade in G1a phase of the cell cycle
7. Trichloroethylene accelerates an autoimmune response in association with Th1 T cell activation in MRL(+/+) mice
8. Molecular and cellular action of butyrate
9. Generation and analysis of Interleukin-4-deficient mice
10. The changing preference of T and B cells for partners as T-dependent antibody responses develop
11. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein
12. Clinical pharmacology os sodium butyrate in patients with acute leukemia
13. Effect of polar organic compounds on leukemic cells: Butyrate-induced partial remission of acute myelogenous leukemia in a child
14. Butyrate derivatives. New agents for stimulating fetal globin production in the β-globin disorders
15. Two levels of help for B cell alloantibody production
16. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
17. Anti-CD3 antibody induces anresponsiveness to IL-2 in Th1 clones but not in Th2 clones